Roche says skin cancer drug substantially shrinks
by on Sep.24, 2011, under Health and Fitness
A new skin cancer drug from Roche had "remarkable" results in a mid-stage trial, substantially shrinking tumors and lesions in patients with a potentially fatal type of skin cancer, the Swiss drugmaker said on Saturday.
View full post on Yahoo! Health News
